Hybrid Senior Accountant II — Biotech GL & SOX Expert

Remote; San Francisco (CA); Hybrid; USD 95,000 - 120,000; Full time

Job summary

BridgeBio invites an experienced accounting professional to join our San Francisco hybrid team. You will manage monthly GL close activities, focusing on debt, royalty liabilities, ASC 350-40 capitalization, and ASC 842 lease accounting, while ensuring SOX compliance and strong internal controls.

You will liaise with multiple business units, prepare journal entries and reconciliations, and support audits and tax requests in a fast-paced biopharma environment.

Qualifications

• Bachelor's degree in accounting or equivalent.
• CPA preferred for progression and compliance understanding.
• 7+ years in a publicly traded company setting is highly preferred.

Responsibilities

• Prepare monthly close workpapers for assigned GL accounts with focus on long-term debt, royalties, ASC 350-40, and ASC 842 lease accounting.
• Review contracts for new POs to ensure proper accounting for expenses, prepaids, and accruals.
• Prepare journal entries and supporting workpapers ensuring quality and compliance.
• Prepare GL reconciliations and fluctuation analyses for assigned accounts.
• Coordinate with other business units to manage prepayments and accruals, and address open items.
• Prepare audit and tax schedules and respond to requests in a timely manner.
• Maintain SOX-compliant documentation and support external audits and internal controls.

Skills

Accounting

CPA preferred

Big 4/SEC experience

Education

Bachelor's degree in accounting

Tools

SAP

Oracle

Coupa

Job description

BridgeBio invites an experienced accounting professional to join our San Francisco hybrid team. You will manage monthly GL close activities, focusing on debt, royalty liabilities, ASC 350-40 capitalization, and ASC 842 lease accounting, while ensuring SOX compliance and strong internal controls.

You will liaise with multiple business units, prepare journal entries and reconciliations, and support audits and tax requests in a fast-paced biopharma environment.